Considering that many patients with T2DM are obese, these agents represent important options among the current therapeutic arsenal
GLP-1 drugs, a class of obesity and diabetes medications that includes Ozempic, Wegovy, Zepbound, and Mounjaro, are known to produce significant weight loss
Through our clinical questionnaire, you can provide essential information about your health and ED symptoms
One softgel daily provides a 120-day supply
Route/evidence mismatch: the pivotal mouse study tested subcutaneous injection at a fixed research dose (20 mg/kg, three times daily) the oral capsule use that is actually sold and discussed commercially has not itself been directly tested in that published research
The choice between oral and injectable Wegovy often depends on patient preference, lifestyle, and medical considerations